BioMarin Pharmaceutical outperformed expectations with a 15.6% increase in year-on-year revenue, reaching $747.3 million, surpassing analyst forecasts...
The Chemours Company recently saw an 8.88% drop in stock price despite a substantial 5.94% dividend yield....
Precision BioSciences unveils PBGENE-HBV, an innovative treatment showing promise in initial ELIMINATE-B trial results against chronic Hepatitis...
Perion Network’s stock dropped nearly 12% following disappointing fourth-quarter financial results. Revenue fell short of expectations at...
Genworth Financial reported a Q4 2024 net loss of $1 million but emphasized significant achievements and future...
The Dutch healthcare technology company, Philips, faces unexpected economic challenges, leading to missed earnings expectations. Philips’ fourth-quarter...
Louisiana-Pacific Corp (LPX) outpaced expectations with a 3.5% rise in net sales, reaching $681 million, driven by...
Nikola Corporation has filed for Chapter 11 bankruptcy, impacting the electric vehicle sector. The bankruptcy filing occurs...
Teva Pharmaceutical Industries is undergoing a transformation from focusing on generic medicines to branded drugs and biopharmaceuticals....
The market reacted mildly to Stryker Corporation’s recent earnings dip, which was due to $1.3 billion in...
